St. Francis Cancer Center | St. Francis Cancer Center | Janssen 6393593MYF2001
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
1320
clinical-trial-template-default,single,single-clinical-trial,postid-1320,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.2,wpb-js-composer js-comp-ver-4.12,vc_responsive

Clinical Trials

Janssen 6393593MYF2001

A randomized, single-blind, Multicenter Phase 2 Study to evaluate the activity of 2 dose levels of imetelstat (GRN163L) in subjects with intermediate-2 or high-risk myelofibrosis (MF) relapsed/refractory to janus kinase (JAK) inhibitor. Read more>

« Available Clinical Trials